Nice article. Excerpt: leronlimab offers a potential long acting, monotherapy maintenance regimen. Similar to ibalizumab, leronlimab has also demonstrated notable virologic suppression results in treatment-experienced, MDR HIV patients who have limited options available. Leronlimab has received fast-track designation,